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Summary 
Previous studies have demonstrated the presence of myocardial depression in clinical and ex- 
perimental septic shock. This depression is associated with the presence of a circulating myo- 
cardial depressant substance with physical characteristics  consistent with cytokines. The present 
study utilized an in vitro myocardial cell assay to examine the role of various human recombi- 
nant cytokines, including tumor necrosis factor (TNF)ot and interleukin (IL)113, in depression of 
cardiac myocyte contractile function induced by serum from humans with septic shock. The 
extent and velocity of electrically paced rat cardiac myocytes in tissue culture was quantified by 
a closed loop video tracking system. Individually, TNF-0c and IL-113 each caused significant 
concentration-dependent depression of maximum extent and peak velocity of myocyte short- 
ening in vitro. In combination, TNF-cx and IL-1[3 induced depression of myocardial cell con- 
tractility at substantially lower concentrations consistent with a synergistic effect. Using immu- 
noabsorption, removal of both TNF-cx and IL-113 (but not either alone) from the serum of five 
patients with acute septic shock and marked reversible  myocardial depression resulted in elimi- 
nation of serum myocardial depressant activity. IL-2, -4, -6, -8, -10, and interferon ~/failed to 
cause significant cardiac myocyte depression over a wide range of concentrations. These data 
demonstrate that TNF-0t and IL-113 cause depression of myocardial cell contraction in vitro 
and suggest that these two cytokines act synergistically to cause sepsis-associated myocardial de- 
pression in humans. 
D 
espite therapy with appropriate antibiotics and inten- 
sive  supportive  care,  septic  shock remains a  serious 
disorder with significant morbidity and mortality. The typical 
human cardiovascular response to septic shock is character- 
ized by hypotension, decreased systemic vascular resistance, 
and elevated cardiac index. In addition, myocardial depres- 
sion manifested by reversible biventricular dilation and re- 
duction of ejection fraction has been shown to be common 
in human septic shock (1-3). 
A previously described in vitro model of myocardial cell 
performance utilizes spontaneously beating rat cardiac my- 
ocytes in culture (4-6). This system allows assessment of  myo- 
cardial  cell performance (i.e.,  contraction) independent of 
changes in preload, afterload, and heart rate. In this system, 
serum from patients with acute septic shock produced in 
vitro depression of cardiac myocyte contractile function (de- 
creased maximum extent and peak velocity of shortening) 
that correlated quantitatively and temporally with the de- 
pression of ventricular ejection fraction seen in the same 
patients in vivo. This suggested the presence of a poten- 
tially pathophysiologicaUy relevant  myocardial depressant 
substance or substances  (5, 6). The identity or identifies of 
the specific molecule(s) responsible for this myocardial de- 
pression have not been determined. 
A number of exogenous and endogenous mediators have 
been implicated in the pathogenesis of septic shock includ- 
ing endotoxin, complement components (particularly  CSa), 
histamine, kinins, prostaglandins, leukotrienes, endorphins 
and cytokines (7,  8).  Potentially, any of these could have 
myocardial depressant effects. However, recent studies have 
suggested that the myocardial depressant substance (or sub- 
stances)  of septic shock possesses physical properties and a 
molecular mass  (10-30  kD)  consistent with cytokines (4, 
9). Cytokines that may potentially contribute to septic myo- 
cardial depression include TNF-cx, IL-113, IL-2, IL-4, IL-6, 
IL-8, IL-10, and IFN-~/.  Each is known to be involved in 
inflammatory states, and serum levels of most are elevated 
in endotoxic and/or septic shock. 
The hypothesis of this study was that one  or more  of 
these factors may be a myocardial depressant and may ac- 
count for some or all of the cardiac depression associated 
with human septic shock. This study was designed to eval- 
uate whether these factors could act as direct myocardial 
depressant substances  in an in vitro model of myocardial 
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human septic serum would attenuate its in vitro myocardial 
depressant activity, 
Materials  and Methods 
The methods employed were a modification of those  previ- 
ously described  (4-6).  The  basic  myocyte assay is  designed to 
measure  the depression  or enhancement of contractility of beat- 
ing cardiac myocytes in cell culture caused by agents that are in- 
troduced into the growth medium. Spontaneously beating new- 
born rat myocardial cells were established using a modification of 
the technique described by Harary  and Farley (10). Using sterile 
technique, hearts  from 2-d-old Lewis  rat  pups  were  removed, 
pooled, and minced into small blocks.  The cells were disaggre- 
gated with 0.15% bovine pancreatic trypsin (Sigma Chemical Co., 
St.  Louis,  MO)  in a  modified HBSS  (potassium,  calcium,  and 
magnesium free; GIBCO BRL, Gaithersburg,  MD). Suspensions 
were centrifuged at 1,500 rpm (500 g) for 15 min and plated into 
35 ￿  10 mm petri dishes at a density of 300,000  cells/ml. Plating 
media (standard control media)  consisted of 25% Hepes-buffered 
Medium 199 and 10% heat-inactivated newborn calf serum (both 
from GIBCO BIKL) diluted in a balanced salt solution and sup- 
plemented with glutamine, penicillin, and streptomycin (all from 
Sigma Chemical Co.). Cells were incubated at 37~  in 5% CO2 
and growth media was changed every 48  h.  After plating, cells 
became confluent and began spontaneously beating within 4 d. 
Latex microbeads were introduced into the culture after 4 d and 
affixed themselves to cell membranes. Beating cells were used for 
the assay between 5 and 10 d after plating. 
All pipettes,  plates, and other equipment used for preparation, 
culture, or testing of cardiac myocytes were endotoxin tested and 
disposable. All liquid media contained < 1 pg/ml endotoxin with 
the exception of newborn calf serum which contained 0.48  ng/ 
ml endotoxin. All recombinant cytokines contained <50 pg en- 
dotoxin per big cytokine. Culture media, cytokine solutions, and 
other test  solutions were  tested  for endotoxin content using a 
quantitative, chromogenic Limulus amebocyte lysate assay (Whit- 
taker M.A. Bioproducts,  Walkersville, MD). 
The extent and velocity of myocardial cell shortening during 
cell contraction was assayed by a modification of previously de- 
scribed techniques (4--6). The petri dish containing  beating myo- 
cardial cells was fastened to the heated (37~  stage of an inverted- 
optics,  phase-contrast  microscope  that  had  an  attached  video 
camera.  A  television monitor displayed  the image of the target 
cells. A custom-built electronic tracking system was used to quan- 
titate the movement of a latex bead selected from the many beads 
attached to the membranes of beating myocytes. The typical maxi- 
mum initial extent of rhythmic displacement of the bead was be- 
tween 3 and 10 p,m, depending on the length of the myocyte to 
which it was adherent. The tracking system produced analog sig- 
nals that were  relayed  to  an intervening electronic instrument 
(which derived contraction velocity from rate of change of bead 
displacement)  and a two-channel strip chart recorder that printed 
an analog recording of extent and velocity of bead displacement. 
To ensure a fixed contraction frequency, a custom-built alternat- 
ing current electrical pulse generator was used to pace myocytes 
(12 V, maximum 40 mA, 0.7-7-ms pulse  duration). The mini- 
mum current and pulse duration required to effectively pace car- 
diac myocytes was used for each experiment. 
Each individual  assay was performed as follows. Plates were re- 
moved from the incubator and fresh growth media applied. Plates 
were mounted on the microscope stage and myocytes were paced 
to 60 contractions per rain. An appropriate  bead was located  and 
the extent and velocity ofmyocyte shortening measured for 5 rain 
(baseline  contractility).  If extent of cell  contraction was  stable 
(maximum 2.5% variation over 5 rain), a test or control solution 
was added.  Subsequently, measurements of maximum extent and 
peak velocity of myocyte shortening and velocity were obtained 
every 5 min for 30 rain. By comparing the maximum extent and 
peak velocity of shortening at each 5-rain interval to the baseline 
value, changes were referenced to initial contractility. 
Five groups  of experiments were performed.  (a)  Human re- 
combinant TNF-o~ and IL-113 were initially assayed (each along 
with controls)  in order to evaluate whether either cytokine could 
individually  produce concentration-dependent  depression  of car- 
diac  myocyte  shortening. The  concentrations tested  were:  for 
TNF-ee (Sigma Chemical Co.), 0 (control), 0.0125, 0.05, 0.2, 0.8, 
3.2,  12.5, 25, 50, and 100 ng/ml (n =  8 each concentration); for 
IL-I~ (Endogen, Inc., Boston, MA), 0  (control),  2,  8,  32,  125, 
500,  and 1,000  ng/ml (n  =  8 each  concentration). Test media 
consisted of standard culture media (as previously described) with 
the addition of the specified cytokine concentrations. 
Reversibility of depression induced by TNF-ot (50 ng/ml) and 
IL-1 [3 (500 ng/ml) was individually  determined by repeated wash- 
out with standard control media (n =  8 each group).  5 min after 
washing,  maximum extent and peak velocity of shortening was 
determined and compared to the level of depression  of similarly 
washed cardiac myocytes exposed only to control media. 
In addition, cardiac  myocytes were separated  from nonmyo- 
cytes  by centrifugation through  a  Percoll step  gradient (Sigma 
Chemical,  Co.)  resulting in a  >95-98% pure  cardiac  myocyte 
culture (viable cardiac myocytes/all viable cells). Myocyte purity 
was determined 48 h after plating by a combination oftrypan blue 
exclusion to differentiate  viable and nonviable cells followed by 
differentiation ofmyocytes from nonmyocytes by cell contraction 
in response  to an electrical pulse.  TNF-ot (50 ng/ml) and IL-I[~ 
(500 ng/ml) were individually  tested for effects on cardiac myo- 
cyte maximum extent and peak velocity of shortening using puri- 
fied cardiac myocyte cultures (n =  8 each group). 
(b) In a second group of experiments, combinations of TNF-c~ 
and IL-113 were evaluated at lower concentrations to evaluate the 
possible additive  or synergistic effects of these cytokines.  In addi- 
tion to  a  control solution without either cytokine, paired test 
concentrations  of TNF-~/IL-I[3  (ng/ml)  included  (a)  0.003: 
0.125;  (b) 0.0125:0.5;  (c)  0.05:2;  (d)  0.2:8  (n =  8 each group). 
Test media consisted of standard culture media as described with 
the addition of the specified cytokine concentrations. 
(c) To determine the specific roles of TNF-ot and IL-113 in car- 
diac myocyte depression  induced by human septic serum, these 
cytokines were removed from serum by immunoabsorption. Se- 
rum from five human survivors with acute septic shock associated 
with  marked,  reversible  depression  of left  ventricular ejection 
fraction  (mean +  standard deviation left ventricular ejection frac- 
tion 26  _  7% during septic shock,  55  +  7% at recovery;  mean 
absolute decrease 28 +  10%) was studied. Each serum sample had 
also been previously documented to contain myocardial  depres- 
sant activity. Serum was treated by exposing it overnight (16 h) at 
4~  to  agarose  beads  bonded  to  specific  rabbit-derived anti- 
human cytokine polyclonal antibodies (Endogen,  Inc.).  Serum 
was treated with antibodies against recombinant human TNF-~x, 
recombinant human IL-IJ3,  both,  or neither (native  antibodies 
derived from rabbits before immunization  with recombinant hu- 
man TNF-oe or IL-I[3). Each serum sample had TNF-ot and IL- 
l13 concentrations determined by ELISA (TNF-ot by T  Cell Sci- 
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Brook, NJ)  (11). The lower limit of detection in these assays was 
20 pg/ml. 
Insuf[icient  serum remained after performing the contractility 
assay to test  cytokine concentrations after  treatment.  However, 
effectiveness of the cytokine immunoahsorption process was con- 
firmed by adding TNF-ot (50  ng/ml)  or IL-l[3 (500  ng/ml) to 
standard media (with 10% serum), similarly treating that serum to 
remove  TNF-u  or  IL-113 using specific  polyclonal  antibodies, 
measuring remaining TNF-cx or IL-113 by ELISA, and confirm- 
ing elimination of depressant  activity in the cardiac myocyte con- 
tractility assay. 
Test solutions  were created by mixing standard  plating media 
without serum with the resultant  (antibody-treated) human septic 
serum  at  a  concentration  of 10%. Four  groups  (and  a  control 
group) were tested to determine serum-induced changes in maxi- 
mum extent  and peak  velocity of cardiac  myocyte shortening. 
The control solution consisted  of 10% neonatal bovine calf serum 
(standard  plating  media)  and  was  cormnon  to  all  experiments 
(nonseptic  control).  The  test  solutions  consisted  of 10%  native 
(septic  control),  anti-TNF-~,  anti-IL-1]3,  or  anti-TNF-ot  and 
anti-IL-113 treated serum (n =  8 each group). Additional control 
solutions  in =  8 each group) consisting of 10% newborn calf se- 
rum treated with antibodies  against recombinant human TNF-~x, 
recombinant human IL-113, both,  or neither  (native  antibodies 
derived from rabbits before immunization with recombinant hu- 
man TNF-ot or IL-113). 
(d) Six other human recombinant cytokines were also initially 
assayed (each  along with controls)  in order to evaluate  whether 
any could individually produce concentration-dependent depres- 
sion  of cardiac  myocyte shortening.  The  concentrations  tested 
were: IL-2, 0 (control),  1.6, 8, 40, 200,  and 1,000 ng/ml (n =  8 
each concentration); IL-4, 0 (control), 1.6, 8, 40, 200, and 1,000 
ng/ml (n =  6 each concentration); IL-6, 0 (control), 0.5, 5, 20, 
80, 320, 1,250, and 3,000 ng/ml in =  8 each concentration); IL-8, 
0 (control),  1.6, 8, 40, 200, and 1,000 ng/ml (n =  7 each concen- 
tration);  IL-10, 0 icontrul),  1.6, 8, 40, 200, and 1,000 ng/ml (n = 
6 each concentration); and IFN-y, 0 icontrol), 4, 16, 64, 250, and 
1,000 ng/ml in =  7 each concentration; all from Endogen, Inc.). 
Where  known,  cytokine concentrations  were selected  based 
on a range from one order of magnitude below to two orders of 
magnitude above the serum cytokine concentrations documented 
during human septic shock. Test media consisted  of standard  cul- 
ture media including 10% neonatal calf serum with the addition 
of the specified cytokine concentrations. 
(e) To study the potential role of endotoxin in cytokine and 
septic  shock  serum-mediated  cardiac  myocyte  depression,  se- 
lected test solutions  were depleted ofendotoxin by overnight co- 
incubation with silica bead-bonded endotoxin neutralizing pro- 
tein derived from horseshoe crab amebocytes (Associates of Cape 
Cod, Inc., Falmouth, MA) and then assayed for myocardial de- 
pressant  activity as  previously described.  Test  media  included 
solutions  containing  TNF-r  (50  ng/ml),  IL-1[3  (500  ng/ml), 
TNF-0e (0.05 ng/ml) with IL-113 (2 ng/ml), or 10% serum from 
one of the five patients  with acute septic shock as well as controls 
containing 10% neonatal calf serum without cytokines or septic 
serum (n =  9 each group). 
Statistical Analysis.  For cytokine testing,  data at all concentra- 
tions and time points were pooled and analyzed by multivariate 
regression  to determine whether a significant  relationship  existed 
between  cytokine concentration or time and degree of cardiac 
myocyte depression. 
Data for the change in maximum extent and peak velocity of 
cardiac myocyte shortening (percent change from baseline) were 
plotted as a function of time for each control and test  solution 
concentration.  Linear regression  analysis was  employed to fit a 
line for the each resulting  plot. For cytokines that were demon- 
strated  to exert depressant  activity,  the slopes of these lines were 
compared to that for the control solution by a two-tailed  Stu- 
dent's t test  in order to determine  at what concentration these 
slopes became significantly  different (i.e.,  at what concentration 
significant  depression  of cardiac  myocyte contractihty occurred). 
In this  manner,  increased  depressant  activity was indicated by a 
more negative value for slope of the regression  hne.  Similarly,  if 
any factor caused  significant  depression,  a two-tailed Student's t 
test was used to determine at what time point significant  depres- 
sion began. 
Data for the comparison of the effects of TNF-oe and IL-113 on 
purified and unpurified cardiac  myocytes were similarly pooled 
for each group. Regression-derived slopes were determined and 
compared to slopes for control media via a two-tailed Student's t 
test. A Bonferonni adjustment for multiple comparisons was apphed 
so that each comparison was considered significant only ifp ~<0.025. 
Similarly,  for analysis of antibody-treated septic serum and for 
endotoxin-removal experiments,  the slope of  the plot for the con- 
trol media was compared to each treatment group by a two-tailed 
Student's t test. A Bonferonni adjustment for multiple  compari- 
sons was again made in both sets of experiments so that each com- 
parison was considered significant only ifp ~<0.0125. 
Results 
Effects of TNF-ee or IL-1~8.  Both TNF-a  and IL-113 in- 
dividually exhibited concentration-dependent depression of 
cardiac myocyte contractility. 
TNF-c~-induced depression  of maximum extent of car- 
diac  myocyte shortening began  at  a  concentration  of 0.8 
ng/ml (p <0.05) and progressed through concentrations of 
3.2  (p  <0.02),  12.5  (p  <0.01),  25  (p  <0.01),  50  (p 
<0.001),  and  100 ng/ml  (p  <0.001).  Fig.  1 A  shows car- 
diac myocyte depression as a function of time for the con- 
trol  media  without  TNF-ot,  0.8  ng/ml  TNF-tx,  and  100 
ng/ml TNF-a. The slopes of the lines fit to the data at each 
concentration were plotted against the log of the  concen- 
trations  (Fig.  1  /9).  A  highly  significant  relationship  (p 
<0.0001)  existed,  suggesting that  increased  depression  of 
maximum extent of myocyte shortening occurred with in- 
creasing  concentrations  of TNF-ot.  Parallel  and  similarly 
significant changes in peak velocity of myocyte shortening 
were also demonstrated. 
Significant  depression  occurred  by  10  min  (p  <0,02) 
with progressively more depression  to 30 min  (p  <0.001) 
for both changes in maximum extent and peak velocity of 
cardiac myocyte shortening.  Overall, TNF-R-induced car- 
diac  myocyte depression  was  significandy time  dependent 
(p <0.0001). 
IL-l[3-induced depression of maximum extent of cardiac 
myocyte shortening began at a concentration  of 32 ng/ml 
(p  <0.05)  and  progressed  through  concentrations  of  128 
(p <0.01), 500 (p <0.01), and 1,000 ng/ml (p <0.001). Fig- 
ure  1 B  shows cardiac myocyte depression as a function of 
time for the control media without IL-113, IL-113 32 ng/ml, 
and  1,000 ng/ml IL-113.  The  slopes  of the  lines  fit to the 
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Figure 1.  The change in maxi- 
mum  extent of myocardial cell 
shortening a~:er exposure to con- 
trol and the specified concentra- 
tions of TNF-tx (A), IL-113 (B), 
or TNF-ot +  IL-113 (C  3. p value 
refers to the difference in slope 
between specified concentrations 
of cytokines and  control media 
without  cytokine. The  slopes 
representing rate of decrease of 
maximum extent of myocardial 
cell shortening in response to dif- 
ferent  cytokine concentrations 
tested are shown in D, E, and F. 
In each case slopes become pro- 
gressively more  negative to  the 
maximum  cytokine concentra- 
tions tested, p value refers to dif- 
ference from 0 slope. A signifi- 
cant p value indicates the existence 
of a concentration-dependent re- 
lationship. Error bars, SEM. 
data at each concentration were plotted against the log of 
the concentrations (Fig. 1 E). As with TNF-ot, a highly sig- 
nificant  relationship  (p  <0.0001)  existed,  suggesting  that 
increased depression of maximum extent ofmyocyte short- 
erring  occurred  with  increasing  concentrations  of IL-1I~. 
Data for changes in peak velocity were similar.  Also similar to 
TNF-a,  significant  depression  of both  maximum  extent 
and peak vdocity of cardiac myocyte shortening occurred 
by  10  min  (p  <0.02)  and  increased  through  30  min  (p 
<0.001).  Depression  was  significantly  time  dependent  (p 
<0.0001) in addition to being concentration dependent for 
both maximum extent and peak velocity of cardiac myocyte 
shortening. 
50 ng/ml TNF-ot and  500 ng/ml IL-113 each also pro- 
duced significant depression  of both maximum extent and 
peak velocity of shortening (p <0.01 each) when applied to 
highly purified  cardiac myocyte tissue  cultures  (>95-98% 
purity versus normal 75-80%). 
Reversal of 50 ng/ml TNF-0t  or 500  ng/ml IL-I[3 in- 
duced depression of  maximum extent (and peak velocity) of 
cardiac myocyte contractility could be produced by wash- 
ing the  cell monolayer with standard growth media with- 
out cytokine (Fig. 2). Contractile function of cardiac myo- 
cytes reverted to baseline within 5 min of washing the cells 
with cytokine-free media. 
Trypan blue supravital staining failed to demonstrate loss 
of cell viability within the cardiac myocyte culture. No in- 
crease in supematant lactate dehydrogenase was noted before 
and after exposure of cardiac myocytes to TNF-o~ or IL-I~. 
Effects of TNF-a and IL-113 in Combination.  Significant de- 
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Figure  2.  Reversibility  of cardiac myocyte depresssion induced by 
TNF-ct or IL-1I~. At 5 rain after  introduction  of  TNF-qx or IL-118,  myo- 
cyte shortening  was similar to control media-exposed  cells. 30 rain after 
exposure to TNF-cx or IL-1I~, cardiac myocyte shortening was signifi- 
cantly decreased  compared  to controls. 5 min after  washing with control 
media, shortening  of TNF-a- and IL-l~-exposed cardiac myocytes  was 
again comparable to similarly washed controls. (*) p <0.01 vs. control 
media cells at the same time point. 
pression of  maximum extent of cardiac myocyte shortening 
was  present  starting  at  a  concentration  of 0.0125  ng/ml 
TNF-ct: 0.5  ng/ml  IL-1{3 (p  <0.05)  with increasing de- 
grees of depression with increasing concentrations through 
to 0.2 ng/ml TNF-ot: 8 ng/ml IL-113 (p <0.001; Fig. 1 C). 
A  highly  significant  relationship  (p  <0.0001)  between 
TNF-cx/IL-lJ3 concentration and depression of maximum 
extent of cardiac myocyte shortening existed (Fig.  1 F'). 
Changes in peak velocity of cardiac myocyte shortening 
were once again entirely parallel except that significant de- 
pression was noted beginning with the lowest concentra- 
tion tested, 0.003 ng/ml TNF-cx with 0.125 ng/ml IL-lJ3 
(p  <0.05),  and progressed through higher concentrations 
to 0.2  ng/ml TNF-ot and 8  ng/ml  IL-113 (p  <0.001).  A 
highly  significant  relationship  between  concentration  of 
TNF-a/IL-lJ3 and degree of depression of  peak velocity of 
cardiac myocyte shortening also  existed  (p  <0.0001).  As 
with TNF-ct and IL-1[3  individually, depression of maxi- 
mum extent and peak velocity of  shortening was first appar- 
ent  by  10  rain  (p  <0.05),  progressed  through  30  rain 
(p <0.001), and was, overall, time dependent (p <0.0001) 
in addition to being concentration dependent. 
Immunoabsorption of TNF-ot and IL-l~S from Human Septic 
Serum.  Five samples  of serum drawn from patients with 
acute septic shock were studied. Measurable TNF-ct con- 
centrations were present in each sample tested before treat- 
ment with anticytokine antibodies. The mean TNF-et con- 
centration of the  samples was  72  +-  26  pg/ml  (mean  +- 
standard deviation). Similarly, IL-1[3 was detectable in un- 
treated serum samples with a mean concentration of 167 -+ 
71  pg/ml. Although insufficient serum remained after im- 
munoabsorption for direct demonstration of cytokine re- 
moval from test (clinical)  serum specimens, efficacy of im- 
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munoabsorption of TNF-ot and IL-1J3  was  confirmed by 
98-99.5% cytokine elimination from standard media with 
10% neonatal bovine serum to which human recombinant 
TNF-ct (50 ng/ml) and IL-113 (500 ng/ml) had been added. 
In addition, such serum was rendered devoid of depressant 
activity in the described cardiac myocyte contractility assay. 
In each case (Fig. 3, A-E), sera treated with preimmune 
rabbit antibodies (septic control) resulted in significant de- 
pression (minimum p  <0.01)  compared to the  10% non- 
septic  neonatal bovine  serum  (nonseptic  control).  Treat- 
ment with anti-TNF-ot or anti-IL-l[3 antibody alone also 
resuked  in  significantly  more  depression  (minimum 
p  <0.05, p <0.01 in four of  five septic sera) than 10% non- 
septic  neonatal  bovine serum.  Immunoabsorption of both 
TNF-cx and I[.-113 from human septic sera resulted in loss of 
depressant activity compared to preimmune antibody-treated 
sera (minimum p <0.01) for all patient sera (i.e., depression 
similar to nonseptic control). Similar results were found for 
changes in peak velocity of shortening in each case. 
Additional control solutions consisting of 10% newborn 
calf serum treated with antibodies against recombinant hu- 
man TNF-ct, recombinant human IL-lJ3, both, or neither 
(native antibodies derived from rabbits before immuniza- 
tion with recombinant human TNF-cx or IL-113) failed to 
affect maximum extent or peak velocity of cardiac myocyte 
shortening compared to media  containing untreated  10% 
newborn calf serum (data not shown). 
Effect of lL-2, -4, -6, -8, -10, and IFN-%  For IL-2 (Fig. 
4 A), -4 (Fig. 4 B), -6 (Fig. 4 C), -8 (Fig. 4 D), -10 (Fig. 4 
E), and IFN-~/(Fig. 4 F), concentration-dependent depres- 
sion  of maximum  extent  of cardiac  myocyte shortening 
was absent over the concentration range tested. Similar re- 
suits were obtained for changes in peak velocity of cardiac 
myocyte shortening for each cytokine tested. 
Effect of Endotoxin Removal  from Test Solutions.  Each  test 
solution from which endotoxin was removed continued to 
demonstrate highly significant depression of maximum ex- 
tent  (and  peak  velocity)  of cardiac  myocyte shortening: 
TNF-ct, p  <0.005; IL-1[3, p <0.001; TNF-ct and IL-lJ3, p 
<0.01;  and 10% septic serum, p  <0.001.  Similar p  values 
were generated for peak velocity data. 
Endotoxin concentration in serum-free media was con- 
sistently  found to  be  <5  pg/ml.  Media  containing  10% 
neonatal calf serum (including those with cytokines) dem- 
onstrated endotoxin concentrations of between 40 and 65 
pg/ml. The patient serum samples  employed in this study 
have  been  evaluated previously as  part  of another study 
(12).  In aggregate,  these samples  were  shown  to  contain 
440 +  120 pg/ml (mean +- SEM) endotoxin. All test solu- 
tions treated with endotoxin neutralizing protein had en- 
dotoxin concentrations of <5 pg/ml. 
Discussion 
The major finding of this study is that a synergistic inter- 
action  of TNF-~t  and  IL-1[3  may be  responsible for the 
myocardial depressant activity of serum from patients with 
acute septic shock. This finding is supported by the experi- A 
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Figure  3.  Regression slopes representing the 
change  of maximum extent of myocardial cell 
shortening (as a function of  time) in response to an- 
ticytokine-treated human septic serum for each pa- 
tient (A-E). Septic serum treated with preimmune 
antibodies (septic  control)  consistently demonstrated 
greater depressant activity than did nonseptic con- 
tro] serum (minimum p <0.01). Only immunoab- 
sorption of  both TNF-~x and IL-1lg  from the septic 
sere resulted in attenuation of serum depressant ac- 
tivity so that myocyte contractility was similar to 
nonseptic controls for each patient. Serum immu- 
noabsorbed of TNF-cx and IL-113 exerted signifi- 
cantly less depressant effect on maximum extent of 
cardiac myocyte shortening than did preimmune 
antibody treated (septic control)  samples (minimum p <0,0I), A Bonferonni adjustment for multiple comparisons  was made so that each comparison was 
considered significant only ifp ~<0,0125, (*) p <0.05; (i') P <0.01; (:[:)  p <0.001 vs, nonseptic control, Error bars, SEM. 
mental data which demonstrate  that immunoabsorption of 
both TNF-~x and IL-113 abrogates in vitro myocardial de- 
pressant  activity of serum  from humans  with  acute  septic 
shock  associated  with  clinical  myocardial  depression  (de- 
creased left ventricular ejection fraction). This conclusion is 
strengthened by additional  data which show that,  whereas 
TNFm  and  IL-113  independently  produce  a  concentra- 
tion-dependent depression of cardiac myocyte contractility, 
the same cytokines in combination produce similar depres- 
sion at far lower concentrations (comparable to those found 
in human septic serum). 
The primary evidence  of the importance  of an interac- 
tion  of TNF-ol  and  IL-113  during  human  septic  shock is 
provided by experiments  involving immunoabsorption  of 
TNF-oL, IL-113, or both from human septic serum. This se- 
rum was drawn from patients with acute septic shock and 
marked reversible myocardial depression as evidenced by a 
decreased  ejection  fraction  (26  ---  7%  during  acute  septic 
shock,  55  -+  7%  after  recovery)  and  had  been  shown  to 
possess a substantial  degree of myocardial depressant activ- 
ity in this in vitro cardiac myocyte assay,  tmmunoabsorp- 
tion of either TNF-ot or IL-113 from this serum resulted in 
relatively little attenuation of myocardial depressant activity 
in  comparison  to  preimmune,  antibody-treated  septic  se- 
rum (septic control). However, immunoabsorption of both 
TNF-ct and IL-113 from the serum resulted in virtual elim- 
ination  of depressant  activity.  This result was seen in each 
of the five individual patient sera tested and was statistically 
highly significant. 
Synergism between TNF-~x and IL-113 in the context of 
this  study  implies  that  complete  elimination  of  either 
should result in loss of serum myocardial depressant activ- 
ity.  There  are  at least  two possible  reasons  for the  limited 
attenuation of serum myocardial depressant activity seen in 
this  study  when  only  TNF-oe  or  IL-113 was  immunoab- 
sorbed.  As we have shown,  immunoabsorption is  not en- 
tirely effective in cytokine removal. The small amounts of 
TNF-cx or IL-113 that  remain may be sufficient to sustain 
synergy. However, when both cytokines are targetted, total 
TNF-oe and IL-113 may drop below the threshold required 
for expression of synergistic activity. Alternately, the gener- 
ation of septic serum-induced cardiac myocyte dysfunction 
may be more complex than a limited interaction between 
TNF-ot and IL-1[~. Although other cytokines have no de- 
monstrable depressant activity of their own, they may pro- 
duce a synergistic effect so that removal of only TNF-cl or 
IL-t13 is inadequate to eliminate serum depressant activity. 
Further  support  for the  synergistic  role  of TNF-oe  and 
IL-113 in septic myocardial depression comes from our ex- 
periments  which show  that,  in  combination,  TNF-oe and 
IL-113 cause  cardiac myocyte depression  at  concentrations 
that  are  incompatible  with  merely additive  depressant  ac- 
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Figure 4.  Slopes  representing  rate of change of  maximum extent of  myocardial  cell shortening  in response to the specified  concentrations  of (A) IL-2, 
(B) IL-4, (C-) IL-6, (D) IL-8, (E) IL-10, and (F) IFN-~/. None of these cytokines  resulted in significant  concentration-dependent  decrease  in maximum 
extent of  cardiac myocyte  shortening. Error bars represent SEM of  the calculated  slopes. 
tivity. Since concentrations of  0.003-0.0125 ng/ml TNF-a 
and 0.125-0.5 ng/ml IL-113 together produce depression of 
maximum  extent  and  peak  velocity of cardiac  myocyte 
shortening, whereas 64-256-fold higher concentrations are 
required to produce depression individually, synergism of 
their depressant activity appears likely. Of note is the fact 
that these concentrations of TNF-o~ and IL-I~ are two to 
three  orders  of magnitude  smaller  than  those  previously 
documented to  cause depression of myocardial tissue  and 
fall well within the range commonly seen in patients with 
severe sepsis and septic shock (11,  13-17). 
A  number of studies  have  inferred a potential role for 
TNF-oc and IL-113 in inflammatory myocardial depression 
by demonstrating that cytokine-containing supematants of 
activated macrophages exhibit myocardial depressant activ- 
ity (decreased myocardial sensitivity to catecholamines; 18, 
19).  However,  cytokine  concentrations in  such  superna- 
tants are typically extremely high compared to levels circu- 
lating during sepsis.  These studies have not demonstrated 
any form of a synergistic action between cytokines in the 
generation of myocardial depressant activity. 
Several previous studies have shown that a combination 
of the two cytokines, TNF-a and IL-I~, exerts synergistic 
hemodynamic effects in a number of  in vivo models of  sep- 
sis  and  septic  shock  (20-22).  Weinberg  et  al.  (20)  have 
shown that doses of LPS, TNF-oc, and IL-113 too low to 
cause a hemodynamic disturbance individually can act syn- 
ergistically to produce hypotension in unanesthetized rab- 
bits. Okusawa et al. (21) have shown that low doses ofIL-1 [3 
in combination with TNF-0t produced a shocklike state in 
rabbits. Waage and Espevik (22)  demonstrated that [L-I~ 
synergistically potentiated the lethal effect of TNF-o~ ad- 
ministered to mice. 
Whereas TNF-~x and IL-113, in combination, cause in vitro 
cardiac myocyte depression at concentrations well within 
the serum range documented in human septic shock, indi- 
vidually each  can  also  cause  cardiac  myocyte depression. 
TNF-a  begins  to  cause  significant  concentration-depen- 
dent depression of cardiac myocyte contraction (both max- 
imum extent and peak velocity of shortening) beginning at 
concentrations within the range documented during septic 
shock (0.2-0.8 ng/ml). This concentration, though, is clearly 
infrequently documented during clinical septic shock. Sim- 
ilarly, cardiac myocyte depression induced by lL-l[3 begins 
at concentrations 4-10 times higher (8-32 ng/ml) than those 
typically documented during human septic shock. Again, only 
rare patients reach such serum levels during clinical septic 
shock. 
Myocardial depression in septic shock has been well char- 
acterized in both spontaneous human septic shock and in 
experimental animal models of septic shock (1-3, 23, 24). 
Available evidence suggests  that myocardial dysfunction in 
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sant substance or substances (4, 6, 7, 9, 25). Early studies of 
a  myocardial depressant  factor associated with  endotoxic 
and septic shock (26, 27) focused on a small  (<1 kD) pep- 
tide of pancreatic origin. Later studies by other groups im- 
phcated at least two distinct factors of unknown chemical 
composition with differing molecular masses  (<1  kD  and 
1-10  kD;  28)  or  a  heat-stable,  lipid-soluble  estrogenic 
compound of <1  kD  (29,  30).  None of these substances 
was definitively identified or isolated. 
The most recent studies attempting to  characterize the 
circulating myocardial depressant substances in human sep- 
tic shock (4)  and canine endotoxic shock (9)  have imph- 
cated a heat-labile, proteinase-sensitive molecule or mole- 
cules ranging from 10 to 30 kD.  Such physical properties 
exclude prostaglandins and leukotrienes but are compatible 
with most known cytokines. 
The human recombinant cytokines used in this study are 
those that have been suggested to play a potential role in 
sepsis  and septic shock in  animals  or humans.  Each,  to a 
varying extent, possesses biologic activity in rat tissues.  At 
one extreme, TNF-et,  IL-I~,  and  IL-6 are  generally ac- 
knowledged to exert a broad range of biologic effects with 
substantial cross-species activity. At the other, IFN-~/ and 
IL-4 exert a narrow range of activity and are, with occa- 
sional exceptions, highly species specific. Other cytokines 
utilized in this study have intermediate ranges ofbioactivity 
and  cross-species  specificity.  Of  the  cytokines  studied, 
TNF-tx, IL-I~, IL-2, and IL-6 have previously been sug- 
gested to cause depression of contractility in some studies 
of in vitro myocardial tissue  (16, 31, 32). 
In  contrast  to  our findings  that  support  a  rapid  (<10 
rain) onset of  cardiac myocyte depression by TNF-et, IL-113, 
and human septic serum, a number of recent studies have 
implicated a  later  onset,  cytokine-mediated [3-adrenergic 
signal transduction defect (18, 33) and/or stimulation of an 
inducible nitric oxide synthetase (19,  34-36) in septic and 
inflammatory myocardial depression.  Depression  of myo- 
cardial tissue  contractility in these studies is delayed (hours 
to  days)  relative  to  the  early  depressant  activity  in  our 
model. Similarly, evidence of relatively delayed (days) de- 
pression  of myocardial contractility in  animal  models  of 
septic shock (23, 37) is parallelled by data that show that in- 
fusion ofendotoxin or TNF can result in early (<1 h) de- 
pression  of cardiac function  (38-40).  Therefore, it seems 
hkely that different processes may be responsible for early 
(14,  16) and late (34-36) cytokine-induced septic myocar- 
dial dysfunction. Such a dual or biphasic, cytokine-driven 
mechanism of inflammatory cardiac dysfunction is consis- 
tent with our observations that the degree of septic serum- 
induced cardiac myocyte depression (occurring within rain 
of exposure)  significantly  correlates  with  the  amount  of 
clinical myocardial depression as measured by decrease in 
ejection fraction (which typically occurs 2-3 d after the on- 
set of sepsis; 2, 6). 
The  specific  intracellular  mechanisms  by  which  cyto- 
kines cause depression of cardiac myocyte contractility in 
this model have not been addressed in this study. However, 
a number of inferences can be made.  First,  the effect does 
not appear to be related to direct cytotoxicity since, in the 
present  study,  lactate  dehydrogenase  levels  are  not  in- 
creased, supravital staining is not decreased, and most im- 
portandy, the cardiac myocyte depressant effect induced by 
TNF-et and IL-1[3 is reversed within minutes after removal 
of cytokines. Second, since depression was  also  produced 
by apphcation of TNF-tx or IL-I~ to  >95-98%  purified 
myocyte cultures, it is unlikely that cytokine-induced pro- 
duction of secondary mediators from cardiac nonmyocytes 
(such as fibroblasts,  endothehal cells, or dendritic cells) plays 
a  significant role.  Third,  since  depression occurs and  re- 
verses within 5-10 min of  introduction or removal ofcyto- 
kine or septic serum, de novo protein synthesis cannot be 
involved. 
A  significant amount of endotoxin is present in most of 
the  test solutions used in  this  study.  Endotoxin has  been 
suggested by one group to have a potential role in suppres- 
sion of the beating rate of neonatal rat cardiac myocytes via 
coinduction (with IL-1[3) of an inducible nitric oxide syn- 
thetase (41).  Others have suggested that a similar inducible 
nitric oxide synthetase dependent mechanism may also ex- 
plain delayed onset depression of myocardial tissue exposed 
to  IL-1[3  or activated macrophage products  (19,  34-36). 
Such a mechanism, whether endotoxin or cytokine driven, 
is  unlikely to  be  relevant in  these  observations since  the 
time frame of the depressant response (<10 rain after the 
introduction of cytokines) is far too rapid to be explained 
by any form of de novo protein synthesis. However, the 
same  authors have correctly pointed out  that  evidence is 
accumulating that nitric oxide has been shown to be pro- 
duced by endotoxin-sfimulated constitutive nitric oxide syn- 
thetase in endothelial cells (42). They have raised the possi- 
bility that endotoxin contamination, rather than cytokine 
effects,  may  account  for  myocardial  tissue  depression  in 
some studies (16). Although endotoxin is clearly present in 
this model, it is unlikely to be the sole cause of depression 
since control samples  (which contain identical amounts of 
endotoxin) would then also be expected to express similar 
depressant activity. In addition, we have demonstrated that 
endotoxin concentrations as high as  1 p,g/ml in this assay 
fail to produce depression of cardiac myocyte contractility 
(43).  Finally, the possibility that endotoxin contributes sig- 
nificandy to TNF-et, IL-113, or human septic serum-induced 
cardiac myocyte depression is strongly refuted by the dem- 
onstration  that  test solutions  depleted  of endotoxin con- 
tinue to exhibit significant myocardial depressant activity. 
There exist two hmitations to this model. First, the neo- 
natal rat cardiac myocytes utilized have the disadvantage of 
not being terminally differentiated as  are adult myocytes. 
Their characteristics change as they age. They exhibit met- 
abolic differences from adult cells including significant dif- 
ferences in membrane receptors (44).  It can be argued that 
phenomena  observed in  neonatal rat myocytes may have 
limited relevance to human adult cardiac pathophysiology. 
However, we have already shown a significant relationship 
between septic serum-induced in vitro cardiac depression 
in  this  model  and  in  vivo  cardiac  depression  (decreased 
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the serum is obtained (4,  6). This argues in favor of the po- 
tential  clinical  relevance  of this phenomenon.  The use  of 
serum-based media, although a necessary component of this 
study,  also introduces  additional  variables.  Apart from the 
cytokines of  interest, serum contains a variety of poorly un- 
derstood,  unidentified  factors that can affect myocyte me- 
tabolism.  However, the use of controls using the same se- 
rum for comparison purposes compensates for this variable. 
The results of this study strongly suggest that a synergistic 
interaction  of TNF-cx and  IL-113 may be at least partially 
responsible  for septic myocardial depression in vivo. Each 
cytokine  is  individually  capable  of myocardial  depressant 
activity at concentrations somewhat higher than those typi- 
cally found  during  human  septic  shock.  In combination, 
however, concentrations of TNF-a  and IL-1~3 well within 
the  range  documented during clinical septic  shock appear 
sufficient to cause myocyte depression, whereas elimination 
of TNF-c~ and IL-1[3 from human septic serum abrogates 
its  depressant  activity.  These  observations  suggest that the 
search for a single myocardial depressant substance in sepsis 
and  shock may be fruitless  because myocardial depression 
in such conditions may be the result of interaction of more 
than one factor. 
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